Stock Market Reviews

VALN (Valneva SE) News

Get the latest news, insights, and market updates on VALN (Valneva SE). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• FDA removes Ixchiq partial pause but tightens vaccine’s use
  The FDA completed a benefit-risk revaluation following two deaths in the French territory of La Réunion.
  Aug 8, 2025 - $VALN
• Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
  Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older and has approved updates to the Prescribing Information (PI) for IXCHIQ®. IXCHIQ® remains indicated in the United States for the prevention of disease caused by the Chikungunya Virus (CHIKV) in individuals 18 years of age and older who are at high risk of
  Aug 7, 2025 - $VALN